Still ... it's worth considering the trade.
Anyone compared NYR-B103 for TBI versus ASX:AGN who are far more advanced and only $92m MC
https://hotcopper.com.au/threads/ann-arg-007-reduces-effects-of-tbi-in-preclinical-study.8002302/
I'm more interested in B103 cardioprotection.
This stock is going to have huge trading cycles. If there are near-the-money options in this raise then 12c will easily be tested (if that's the CR price) so let's keep the gap to 7.5c in mind.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.025(10.0%) |
Mkt cap ! $47.45M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 22.5¢ | $209.3K | 892.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7150 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 416666 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |